Shock Nursing Management – Assessment, Diagnosis & Care

Shock nursing management depends on the accurate and timely identification of shock. This can be obtained through an accurate assessment, thorough investigations, and a proper diagnosis, following which, the right treatment and requirements can be planned and provided to the patient.

Assessment

When assessing for shock, one should keep in mind that clinical changes are initially quite subtle. Still, the following aspects must be taken into account during an initial patient assessment…

  • patient history
  • level of consciousness
  • signs of internal or external bleeding
  • skin colour and/or moisture
  • respiratory rate and effort
  • heart rate and rhythm
  • body temperature
  • blood pressure
  • urine output
shock nursing management
Retrieved from https://www.grepmed.com/images/4224/types-table-signs-classification-symptoms on 16th January 2023
shock nursing management
Retrieved from https://doctorlib.info/medical/harrisons-manual-medicine/12.html on 16th January 2023

Investigations

Clinical tests should be carried out to confirm shock and identify the patient’s array of needs…

  • CBC – a complete blood count test measures the amount of red blood cells (which carry oxygen) and white blood cells (which fight infection); this test gives a good indication of bleeding and infection.
  • ABGs – an arterial blood gases test measures the acidity (pH) and the levels of oxygen and carbon dioxide in arterial blood; this test determines how well the patient’s lungs are performing gas exchange.
  • Lactate Level – normal blood lactate levels are 1.3 mmol/L; an increase in lactate production is usually caused by impaired tissue oxygenation whereby the lungs switch from performing aerobic to anaerobic respiration.
  • Cross Match – this is done in case the patient is found to be needing a blood transfusion.
  • Electrolytes electrolyte imbalance can be indicative of shock in the progressive phase.
  • Clotting – impaired coagulation and microclots are indicative of shock in the progressive phase.
  • Alcohol Levels – these are tested if the patient suffered from trauma.
  • ECG – an ECG determines whether the patient is suffering from arrhythmias or is heading towards cardiac depression and failure.
  • Cardiac Enzymes – cardiac enzymes a.k.a. cardiac biomarkers are released by the heart in the case of heart damage or stress caused by low oxygen; Troponin and creatinine phosphokinase (CPK) levels rise following a heart attack; elevated heart enzyme levels may also indicate acute coronary syndrome or ischaemia.
  • X-rays, CT scan of the Patient’s Chest, Abdomen and Spine – determines if there is infection, injury, and fluid loss.
shock nursing management
Retrieved from https://oxfordmedicalsimulation.com/learning/blood-gases/normal-blood-gas-sig001us/ on 16th January 2023
Retrieved from https://veteriankey.com/blood-gas-acid-base-analysis-and-electrolyte-abnormalities/ on 16th January 2023

Diagnosis

Clinical manifestations of shock vary according to both the underlying cause and the stage it is at, varying based on the cause of shock as well as the patient’s physiological response.

Typically, a patient is considered to be in shock when the following signs are noted:

  1. a systolic blood pressure of <90mmHg
  2. tachycardia OR bradycardia
  3. altered mental status

Shock Nursing Management

Shock nursing management aims to:

  • RESTORE ADEQUATE TISSUE PERFUSION – this can be achieved through ensuring adequate oxygen delivery to the cells in relation to gas exchange, cardiac output, and haemoglobin, as well as improving oxygen utilisation by the cells
  • PREVENT SHOCK PROGRESSION INTO FURTHER STAGES

Thus, in shock nursing management, the following steps need to be tackled as needed:

  1. improving oxygen supply
  2. administering fluid therapy
  3. administering cardiovascular drugs
  4. providing nutritional support
  5. providing psychosocial care

1. Improving Oxygen Supply

With adequate oxygen supply we aim to:

  • achieve adequate gas exchange – ensure the patient has a patent airway, and improve ventilation and oxygenation by providing supplemental oxygen and mechanical ventilation if required
  • achieve adequate cardiac output – aim to control the patient’s heart rate, preload and afterload, and cardiac contractility through the administration and titration of fluids and cardiovascular drugs

2. Administering Fluid Therapy

Fluid therapy administration is necessary for all types of shock, though the type of fluid administered and the amount and speed of delivery varies with every patient.

Fluids help increase oxygenation since oxygenation is partly affected by circulation. Types of fluids administered include:

  • crystalloids – electrolyte solutions such as Isotonic (eg. normal saline or RLactate), Hypertonic (eg. 10% Dextrose) or Hypotonic (eg. 0.45% NaCl – Sodium Chloride)
  • colloids – types of colloids, which contain large molecules, include blood and its products such as Fresh Frozen Plasma (FFP), as well as synthetic plasma expanders such as Gelafundin (a colloidal plasma volume substitute in an isotonic balanced whole electrolyte solution that can be used for prophylaxis and therapy of hypovolaemia and shock); ADVANTAGES: colloids remain in the intravascular space, restoring fluids faster and with less volume, while blood restores Hgb; DISADVANTAGES: colloids are expensive, may cause reactions, and may also leak out of damaged capillaries, causing additional problems especially within the lungs

fluid administration Complications

Common fluid administration complications include cardiovascular overload and pulmonary oedema.

Patients with increased risk include elderly patients and patients with a history of chronic renal failure or heart failure.

To avoid fluid administration complications, the nurse should:

  • monitor and document urine output and fluid intake
  • monitor for changes in the patient’s vital signs
  • check for lung sounds
  • perform haemodynamic monitoring

3. Administering Cardiovascular Drugs

Anti-dysrhythmic agents

  • anti-dysrhythmic agents such as Amiodarone prevent or treat abnormal heart rates and rhythms

Vasodilators

  • vasodilators such as nitrates cause arterial dilation by decreasing the afterload following decreased resistance to blood ejection, leading to an increase of cardiac output without increased oxygen demands
  • vasodilators also cause venous dilation by reducing the preload and subsequently reducing the filling pressure on the failing heart

NOTE: Vasodilators REDUCE BLOOD PRESSURE! Monitor patient at all times whilst on vasodilators!

Inotropes and Vasoconstrictors

  • inotropes and vasoconstrictors increase myocardial contractility leading to an increase in cardiac output
  • inotropes stimulate adrenergic receptors, causing similar effects to the fight or flight reaction; types of sympathomimetic agents include naturally occurring catecholamines eg. adrenaline, noradrenaline and dopamine; synthetic cathecolamines eg. dobutamine

NOTE: Vasoconstrictors INCREASE BLOOD PRESSURE!

ADRENALINE (EPINEPHRINE)

  1. binds to beta 1 and beta 2 receptors
  2. cause an increase in heart rate, cardiac contractility, vasodilation, and cardiac output
  3. with an increasing rate of infusion also comes an increase in alpha receptors, which result in increased blood pressure and vascular resistance through vasoconstriction
  4. the heart now needs to work harder and so, its oxygen demand increases too

NORADRENALINE

  1. binds to beta 1 receptors only
  2. does not cause an increase in heart rate
  3. a low dose of noradrenaline increases cardiac contractility, leading to an increase in cardiac output
  4. higher doses tend to limit effect due to alpha stimulation which causes massive vasoconstriction
  5. whilst this causes an increase in blood pressure, it compromises peripheral circulation and increases the workload of the heart

DOPAMINE

  1. dopamine is the chemical precursor of noradrenaline
  2. a low dose of dopamine stimulates dopaminergic receptors, causing renal and mesentric vasodilation, leading to a good urine output
  3. a moderate dose of dopamine stimulates beta 1 receptors, causing an increase in cardiac contractility and cardiac output
  4. a high dose of dopamine stimulates alpha receptors, causing massive vasoconstriction, an increase in blood pressure, and an increase in the workload of the heart

DOBUTAMINE

  1. dobutamine causes no dopaminergic effects
  2. dobutamine mainly stimulates beta 1 receptors, causing an increase in cardiac contractility and cardiac output; dobutamine may also stimulate beta 2 receptors, causing mild vasodilation, causing a reduction the the preload, afterload, and stress on the heart
  3. dobutamine is helpful in treating heart failure, especially in hypotensive patients who are unable to tolerate vasodilators
  4. dobutamine may also be used as an adjunct therapy to adrenaline or noradrenaline and dopamine to reduce vasoconstriction effect

ADMINISTRATION OF INOTROPES:

  • correct dilution of inotropes is of utmost importance
  • inotropes are administrated as infusions through electronic pumps so that consistent administration is ensured
  • administration of inotropes is done through a central line
  • careful haemodynamic monitoring is very important especially since it help in the titrating process of inotropes dosage as needed
  • inotropes should NOT replace fluid and electrolyte balance
  • inotropes should be weaned off slowly

EFFECTS OF ADRENERGIC RECEPTORS

RECEPTORLOCATIONRESPONSE
ALPHAskin, muscles, kidneys, and intestinesconstrict peripheral arterioles
BETA 1cardiac tissueincrease heart rate and cardiac contractility
BETA 2vascular and bronchial smooth muscledilates peripheral arterioles; increases heart rate; causes bronchodilation

4. Providing Nutritional Support

Shock causes increased metabolic rates, which in return increase the patient’s energy requirements. Catecholamines (adrenaline and noradrenaline) deplete glycogen stores in 8-10 hours, after which the body starts breaking down skeletal muscle for energy. This prolongs recovery period unless it is prevented.

Typically, a patient in shock may require >3000kcal daily, however, the patient is usually unable to eat due to intubation, sedation, and anxiety. For this reason, enteral or parenteral nutrition should be initiated within 48 hours, and increased to full nutrition by day 3-7, if the patient is haemodynamically stable (excessive nutrient intake should be avoided in the early phase of critical illness).

NOTE: patients diagnosed with shock are also prone to develop pressure ulcers.

5. Providing Psychosocial Care

Psychological care should be provided throughout the whole course of hospitalisation, especially within the critical care environment. Liaise with other healthcare professionals as needed.

Whilst adopting an empathic approach, provide information and reassurance to both the patient (if conscious; if unconscious still talk to your patient as if he/she is listening, making him/her aware of what is going on in relation to care) and relatives, as this reduces anxiety. Communicate with the patient’s relatives about the patient’s condition as well as procedures being performed.

Shock Nursing Management Additional Interventions

  • ensure good vascular access for fluid administration, central venous pressure (CVP) monitoring, and to draw blood for investigations
  • insert a NGT (or OGT if patient has facial trauma) so that emesis (vomiting) and aspiration are prevented
  • insert a urinary catheter to monitor urine output and fluid balance accordingly
  • monitor the patient’s temperature and ensure maintenance of normal body temperature
  • reposition patient frequently to prevent pressure ulcer formation
  • provide frequent mouth and eye care
  • assess for pain and administer analgesics as needed
  • ensure continuous monitoring and documentation

Did you find the above nursing information useful? Follow us on Facebook and fill in your email address below to receive new blogposts in your inbox as soon as they’re published 🙂

The Endocrine System – Hypothalamus & Pituitary Gland

The endocrine system is made up of hormone-producing glands within the body which facilitate communication between cells. Glands that make up the endocrine system include the hypothalamus, pituitary gland, and pineal gland, all of which can be found within the brain; the thyroid and parathyroid glands which can be found in the neck; the thymus which is situated between the lungs; the adrenals, which sit on the kidneys; the pancreas, which is found behind the stomach; and the ovaries (women) or testes (men) which are in the pelvic region.

endocrine system hypothalamus and pituitary gland
Retrieved from https://www.blendspace.com/lessons/tv-3ufAxEQI3pQ/group-3-307-313-331-endocrine-system on 3rd March 2022

Within the endocrine system, an endocrine gland or tissue releases an amount of hormone, which amount is determined by the body’s need for that hormone. Through sensing and signalling systems, hormone-producing cells receive information and regulate hormone release amount and duration. Released hormones are carried by the blood to target cells, which contain receptors that bind the hormone, leading to the desired effect. This effect is then recognised by secretory cells through a feedback signal. Once the required hormonal effect is fully accomplished, the hormones are either removed by the liver or the kidneys, or else degraded by the target cells.

Hormonal secretion is regulated by negative feedback control so homeostasis within the body is maintained.

The Hypothalamus

The hypothalamus, which is located below the thalamus, acts as a link between the nervous system and the endocrine system. It receives inputs from various parts of the brain, and sensory signals from internal organs and the retina. Changes are triggered in the hypothalamic activity due to pain, stress, and other emotional factors. The hypothalamus controls the autonomic nervous system and regulates various bodily factors such as temperature, hunger and thirst, sexual behaviour, and defensive reactions.

The Endocrine System - Hypothalamus & Pituitary Gland
Retrieved from https://kids.frontiersin.org/articles/10.3389/frym.2021.534184 on 3rd March 2022

Within the hypothalamus are clusters of specialised neurons – neurosecretory cells, which synthesise the hypothalamic hormones in their cell body. The hormones are transported inside vesicles by axonal transport.

Hypothalamus-Released Hormones

The hypothalamus is an important endocrine gland that produces hormones which, after being released into the blood, travel in the portal veins to a secondary capillary bed found in the anterior lobe of the pituitary, where their effects are produced. Hormones released in this way include:

  • Thyrotropin-releasing hormone (TRH) – related to thyroid gland growth and function
  • Gonadotropin-releasing hormone (GnRH) – related to the reproductive system
  • Growth hormone-releasing hormone (GHRH) – related to growth
  • Corticotropin-releasing hormone (CRH) – related to hormone secretion
  • Somatostatin – related to the growth hormone
  • Dopamine – acts as a neurotransmitter

Hormones which travel in the neurons to the posterior lobe of the pituitary before being released into circulation include:

  • Antidiuretic Hormone (ADH) / Vasopressin – promotes regulation of the amount of water within the body
  • Oxytocin – involved in childbirth and breastfeeding

The Pituitary Gland

The pituitary gland, which measures just about 1.3cm in diameter, is located in the cella turcica of the sphenoid bone. It is attached to the hypothalamus via the infundibulum – a stalklike structure. Pituitary gland hormones regulate body activities. The pituitary gland is divided into two lobes: the anterior lobe and the posterior lobe.

The pituitary gland anterior lobe accounts to around 80% of the pituitary gland. It is involved in growth regulation, metabolism, and reproduction, through its produced hormones. Hormone production happens through stimulation or inhibition by chemical messages originating from the hypothalamus. Thus, hypothalamic hormones act as a link between the nervous system and the endocrine system. They reach the anterior pituitary through the Hypophyseal Portal System.

The pituitary gland posterior lobe is involved in hormone transmission. Hormones originating from neurons within the region of the hypothalamus are secreted directly into peripheral circulation.

The lobes are divided by the pars intermedia – a relatively avascular zone.

The Endocrine System - Hypothalamus & Pituitary Gland
Retrieved from https://www.nature.com/articles/nrdp201692 on 5th March 2022

The 5 Types of Glandular Cells

  1. Somatotroph Cells – produce GH (growth hormone) which is responsible for general body growth
  2. Lactotroph Cells – synthesise PRL (prolactin) which promotes milk production by the mammary glands
  3. Corticolipothroph Cells – synthesise ACTH (adrenocorticotropic hormone) which stimulates hormone secretion, and MSH (melanocyte-stimulating hormone) which is responsible for skin pigmentation
  4. Thyrothroph Cells – produce TSH (thyroid-stimulating hormone), which controls the thyroid gland
  5. Gonadotroph Cells – produce FSH (follicle-stimulating hormone), which stimulates egg and sperm production in the ovaries and testes, and LH (luteinizing hormone), which stimulates other sexual and reproductive activities.
The Endocrine System - Hypothalamus & Pituitary Gland
Retrieved from http://www.pharmacy180.com/article/pituitary-gland-3595/ on 5th March 2022

Growth Hormone (GH)

  • is released through two regulating factors from the hypothalamus, namely GHRF (growth hormone releasing factor) and GHIF (growth hormone inhibiting factor) or Somatostatin
  • causes cells to grow and multiply by increasing the rate at which amino acids enter the cells to be built up into proteins
  • acts on the skeleton and the skeletal muscles firstly by increasing their growth rate, and then maintaining their size when growth is attained
  • increases the rate of protein synthesis a.k.a. protein anabolism
  • promotes fat catabolism by causing cells to change from burning carbohydrates to burning fats to produce energy
  • accelerates rate at which glycogen stored within the liver converts into glucose and releases itself into the blood
  • converts other factors into growth-promoting substances – somatomedins and insulin-like growth factors (IGF), both of which are similar to insulin yet more potent than insulin

Growth Hormone Secretion Stimuli and Inhibition

Retrieved from https://basicmedicalkey.com/normal-endocrine-function/ on 5th March 2022

Prolactin (PRL)

  • requires priming of the mammary glands through oestrogens, progesterone, corticosteroids, growth hormone, thyroxine, and insulin
  • initiates and maintains milk secretion by the mammary glands (amount of milk is determined by oxytocin)
  • has an inhibitory and an excitatory negative control system
  • level rises during pregnancy, falls right after delivery, and rises again during breastfeeding, which is why in the 1st two days following birth, mothers do not produce milk but colostrum

NOTE: women on oral contraceptives may experience lack of milk production due to their hormonal effect.

Melanocyte-Stimulating Hormone (MSH)

  • increases skin pigmentation through the stimulation of melanin granules dispersion in melanocytes
  • secretion is stimulated by the melanocyte-stimulating hormone releasing factor (MRF), or inhibited by the melanocyte-stimulating hormone inhibiting factor (MIF)
  • lack causes the skin to look pallid
  • excess causes the skin to look dark

Thyroid-stimulating factor (TSH)

  • stimulates the synthesis and secretion of hormonal production within the thyroid gland
  • secretion is controlled by the thyrotropin releasing factor (TRF), which is released based on thyroxine blood level, metabolic rate of the body, and other factors through a negative feedback system

Adrenocorticotropic Hormone (ACTH)

  • controls the production and secretion of some adrenal cortex hormones
  • is secreted by the hypothalamic regulating factor called corticotropin releasing factor (CRF), which is released depending on stimuli and hormones through a negative feedback system

Follicle-Stimulating Hormone (FSH)

  • in females initiates the development of an ova every month, and stimulates cells within the ovaries to secrete oestrogens
  • in males stimulates the testes to produce sperm
  • secretion depends on the hypothalamic regulating factor gonadotropin releasing factor (GnRF), which is released in response to oestrogens in females, and to testosterone in males through a negative feedback system

Luteinizing Hormone (LH)

  • along with oestrogens, in females it stimulates the release of an ovum within the ovary, prepares the uterus for the implantation of the fertilised ovum, stimulates the formation of the corpus luteum in the ovary to secrete progesterone, and prepares the mammary glands for milk secretion
  • in males it stimulates the interstitial endocrinocytes in the testes to develop and secrete testosterone
  • secretion is controlled by GnRF, which works through a negative feedback system

Pituitary Gland Posterior Lobe

The posterior lobe of the pituitary gland a.k.a. neurohypophysis, does not synthesise hormones. It releases hormones to the circulation via the posterior hypophyseal veins to be distributed to target cells in other tissues. The cell bodies of the neurosecretory cells produce Oxytocin (OT) and Antidiuretic Hormone (ADH) / Vasopressin.

Oxytocin (OT)

  • is released in high amounts just before birth
  • stimulates contraction of smooth muscle cells in the pregnant uterus
  • stimulates the contractile cells around the mammary gland ducts
  • affects milk ejection
  • works through a positive feedback cycle which is broken following birthing
  • is inhibited by progesterone, but can work in conjunction to oestrogens

Antidiuretic hormone (ADH)

  • affects urine volume; it causes the kidneys to excrete water from fresh urine and return it to the bloodstream, reducing urine volume
  • absence causes an increase in urine output
  • raises blood pressure by constricting arterioles
  • secretion varies based on the body’s needs
  • causes a decrease in sweat
Retrieved from https://slideplayer.com/slide/10623655/ on 6th March 2022

Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂